Literature DB >> 19945904

Worldwide frequency of G2019S LRRK2 mutation in Parkinson's disease: a systematic review.

L Correia Guedes1, J J Ferreira, M M Rosa, M Coelho, V Bonifati, C Sampaio.   

Abstract

BACKGROUND: The LRRK2 G2019S mutation is the most frequent known cause of familial and sporadic Parkinson's disease. Knowledge of its worldwide frequency distribution is essential for clinical and molecular research as well as genetic counseling.
OBJECTIVES: To conduct a systematic review of the reported frequency of G2019S in different populations and to assess critically the quality of the clinical studies.
METHODS: We conducted a systematic review of all published papers on G2019S frequency in homogeneous ethnic groups or sub-groups of patients. Selected papers were analyzed for methodological quality.
RESULTS: 68 studies from 32 countries were included in the analysis. A heterogeneous distribution was observed with high frequencies in North African Arab countries, the Middle East, southern Europe, North American Ashkenazi Jewish populations and in South American countries with known European ethnic influence. Frequencies ranged from the no cases to 35.7% in sporadic and 42% in familial North-African Arab patients. Only one paper from one sub-Saharan country was found. Methodological pitfalls were identified.
CONCLUSIONS: Estimated frequencies were found to be variable, which may reflect ethnic differences and methodological discrepancies. We make recommendations on the methods of selection of participants and on the definition of familial Parkinson's disease to improve the quality of frequency studies on LRRK2 mutations. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19945904     DOI: 10.1016/j.parkreldis.2009.11.004

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  46 in total

Review 1.  Genetic mouse models for understanding LRRK2 biology, pathology and pre-clinical application.

Authors:  Zhenyu Yue
Journal:  Parkinsonism Relat Disord       Date:  2012-01       Impact factor: 4.891

2.  Clinical expression of LRRK2 G2019S mutations in the elderly.

Authors:  Marta San Luciano; Richard B Lipton; Cuiling Wang; Mindy Katz; Molly E Zimmerman; Amy E Sanders; Laurie J Ozelius; Susan B Bressman; Rachel Saunders-Pullman
Journal:  Mov Disord       Date:  2010-11-15       Impact factor: 10.338

3.  LRRK2(I2020T) functional genetic interactors that modify eye degeneration and dopaminergic cell loss in Drosophila.

Authors:  Paul C Marcogliese; Sameera Abuaish; Ghassan Kabbach; Elizabeth Abdel-Messih; Sarah Seang; Gang Li; Ruth S Slack; M Emdadul Haque; Katerina Venderova; David S Park
Journal:  Hum Mol Genet       Date:  2017-04-01       Impact factor: 6.150

4.  Non-motor symptoms in Chinese Parkinson's disease patients with and without LRRK2 G2385R and R1628P variants.

Authors:  Da-Wei Li; Zhuqin Gu; Chaodong Wang; Jinghong Ma; Bei-Sha Tang; Sheng-Di Chen; Piu Chan
Journal:  J Neural Transm (Vienna)       Date:  2014-07-26       Impact factor: 3.575

5.  Mutant of leucine-rich repeat kinase 2 is not associated with non-motor symptoms in Chinese Parkinson's disease patients.

Authors:  Maolin Hao; Ning Pan; Qinghua Zhang; Xiaohong Wang
Journal:  Int J Clin Exp Med       Date:  2014-08-15

6.  The screening of the 3'UTR sequence of LRRK2 identified an association between the rs66737902 polymorphism and Parkinson's disease.

Authors:  Lucía F Cardo; Eliecer Coto; René Ribacoba; Ignacio F Mata; Germán Moris; Manuel Menéndez; Victoria Alvarez
Journal:  J Hum Genet       Date:  2014-04-24       Impact factor: 3.172

Review 7.  α-Synuclein, leucine-rich repeat kinase-2, and manganese in the pathogenesis of Parkinson disease.

Authors:  Jason P Covy; Benoit I Giasson
Journal:  Neurotoxicology       Date:  2011-01-14       Impact factor: 4.294

8.  Type II kinase inhibitors show an unexpected inhibition mode against Parkinson's disease-linked LRRK2 mutant G2019S.

Authors:  Min Liu; Samantha A Bender; Gregory D Cuny; Woody Sherman; Marcie Glicksman; Soumya S Ray
Journal:  Biochemistry       Date:  2013-03-01       Impact factor: 3.162

Review 9.  Genetics in Parkinson disease: Mendelian versus non-Mendelian inheritance.

Authors:  Dena G Hernandez; Xylena Reed; Andrew B Singleton
Journal:  J Neurochem       Date:  2016-04-18       Impact factor: 5.372

10.  Regulation of myeloid cell phagocytosis by LRRK2 via WAVE2 complex stabilization is altered in Parkinson's disease.

Authors:  Kwang Soo Kim; Paul C Marcogliese; Jungwoo Yang; Steve M Callaghan; Virginia Resende; Elizabeth Abdel-Messih; Connie Marras; Naomi P Visanji; Jana Huang; Michael G Schlossmacher; Laura Trinkle-Mulcahy; Ruth S Slack; Anthony E Lang; David S Park
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.